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Summary
Animal oocytes undergo a highly conserved develop-
mental arrest in prophase of meiosis I. The mainte-
nance of the prophase I arrest requires the silencing
of Cdk1 activity. Drosophila oocytes inhibit the ac-
cumulation of the mitotic cyclins, the activating sub-
units of Cdk1, via a poorly defined posttranscriptional
mechanism. Here, we demonstrate that the transla-
tional repressor Bruno binds the 30 UTR and inhibits
the translation of the mitotic cyclin Cyclin A during
prophase of meiosis I. In the absence of Bruno, ovar-
ian cysts enter meiosis but rapidly accumulate high
levels of mitotic cyclins and return to themitotic cycle.
Based on our results, we propose a model in which
Bruno and the anaphase-promoting complex/cyclo-
some act together to restrict the accumulation of the
mitotic cyclins, and thus Cdk1 activity, during the pro-
phase I arrest of the Drosophila oocyte.
Introduction
Arrest of the oocyte cell cycle in prophase of meiosis I
(prophase I) is a universally conserved feature of animal
oogenesis (Kishimoto, 2003; Page and Orr-Weaver,
1997). During the prophase I arrest, animal oocytes
must perform two seemingly contradictory tasks. First,
they must accumulate and store large quantities of
mRNAs and proteins that are required to drive the two
future meiotic divisions as well as the mitotic divisions
of the early embryo. Second, they must remain fully ar-
rested in order to maintain the integrity of the genome
and avoid producing an aneuploid gamete. An important
factor in maintaining the prophase I arrest is the inhibi-
tion of the mitotic kinase Cdk1 (Jones, 2004). The preco-
cious activation of Cdk1 might force the oocyte back
into the mitotic cycle or, alternatively, result in prema-
ture entry into the first meiotic metaphase. Thus, oo-
cytes must inhibit Cdk1 activity at the onset of meiosis,
but they must be able to activate the mitotic kinase later
in oogenesis when they resume the meiotic cycle. While
it is one of the most highly conserved events of gameto-
genesis, the precise developmental and cell cycle
events that initiate and maintain the prophase I arrest
are not fully understood.
Drosophila melanogaster provides a genetically ame-
nable system by which to examine how the meiotic cycle
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650-0047, Japan.is coordinated with the developmental events of oogen-
esis. The Drosophila ovary is comprised of approxi-
mately 20 ovarioles, which consist of a row of egg cham-
bers in successively older stages of development
(Figure 1A) (Spradling, 1993). Drosophila have meroistic
ovaries in which the oocyte develops within the context
of a 16-cell interconnected germline cyst. Ovarian cysts
are produced in region 1 of the germarium, which lies at
the tip of the ovariole (Figure 1B), through a series of four
synchronous divisions with incomplete cytokinesis (de
Cuevas et al., 1997; McKearin, 1997). Upon the comple-
tion of the 4 cyst divisions, all 16 cells enter premeiotic S
phase. Next, in region 2 of the germarium, a meiotic gra-
dient forms in which up to four cells construct extensive
synaptonemal complexes (SCs) (Carpenter, 1975, 1979;
Chandley, 1966; Schmekel et al., 1993). Ultimately, the
SCs recede in all cyst cells, except in the one true oo-
cyte. In stage 1 of oogenesis, as egg chambers bud off
from the germarium, 15 of the cells enter a variant cell
cycle called the endocycle, in which repeated rounds
of DNA synthesis occur in the absence of mitosis (Edgar
and Orr-Weaver, 2001; Lilly and Duronio, 2005). These
cells go on to develop as polyploid nurse cells and serve
to feed the growing oocyte. In contrast, the oocyte re-
mains arrested in prophase of meiosis I until late in oo-
genesis, before proceeding on to the first meiotic meta-
phase in stage 14.
Although the cell cycles that produce a polyploid
nurse cell versus an arrested prophase I oocyte have ob-
vious differences with regard to the regulation of Cyclin
E/Cdk2 kinase activity and DNA replication (Hong et al.,
2003), these two variant cell cycles share one important
common feature: they both depend on the inhibition of
Cdk1 activity (Hayashi, 1996; Sauer et al., 1995; Sigrist
and Lehner, 1997; Weigmann et al., 1997). In Drosophila,
the mitotic cyclins, Cyclin A and Cyclin B, serve as acti-
vating subunits of Cdk1 (Lehner and O’Farrell, 1990). In
ovarian cysts, the accumulation of the mitotic cyclins
is posttranscriptionally regulated. Coincident with the
onset of meiosis, the transcription of the mitotic cyclins
Cyclin A and Cyclin B is upregulated in region 2 of the
germarium at the mitotic/meiotic boundary, with the
continued accumulation of the transcripts observed
throughout oogenesis (Dalby and Glover, 1992). How-
ever, while the levels of the Cyclin A and Cyclin B tran-
scripts are high, the levels of Cyclin A and Cyclin B pro-
tein remain below the level of detection (Dalby and
Glover, 1992; Lilly et al., 2000; Reed and Orr-Weaver,
1997). These data suggest that ovarian cysts may re-
strict inappropriate Cdk1 activity during meiosis by pre-
venting the accumulation of the mitotic cyclins.
The phenotype observed in morula (mr) mutants con-
firms the functional importance of limiting mitotic cyclin
expression in developing ovarian cysts (Reed and Orr-
Weaver, 1997). mr encodes the anaphase-promoting
complex/cyclosome (APC/C) subunit APC2 (Kashevsky
et al., 2002). The APC/C is an E3 ubiquitin ligase that tar-
gets Cyclin A and Cyclin B for destruction by the 26S
proteasome (Vodermaier, 2004). In the hypomorphic fe-
male sterile mutants, mr1 and mr2, oogenesis initially
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128Figure 1. z2286 Ovarian Cysts Fail to Down-
regulate Mitotic Cyclin Levels during Meiosis
(A) A diagram of an ovariole. Note that the oo-
cyte remains in prophase of meiosis I for the
growth phase of oogenesis.
(B) A diagram indicating the three subdivi-
sions of the germarium.
(C–F) (C) Wild-type and (D) z2286 ovarioles
stained with the DNA dye DAPI. Note that in
z2286, the numbers of cells per egg chamber
increases with developmental age. (E) Wild-
type and (F) z2286 ovarioles from (C) and
(D), labeled with aCyclin B (green) and
aC(3)G (red).
(G–H) (G) A wild-type and (H) z2286germarium
stained with aCyclin B (green) and aC(3)G
(red). Note that in a wild-type germarium, Cy-
clin B expression decreases soon after ovarian cysts enter the meiotic cycle and express the SC component C(3)G (arrowhead). (H) In contrast, in
z2286 mutants, aC(3)G-positive cysts accumulate high levels of Cyclin B (asterisk). The arrows in (E) and (G) indicate Cyclin B expression in the
somatically derived follicle cells, which continue to proliferate until stage 6 of oogenesis.proceeds normally, with the oocyte arresting in pro-
phase of meiosis I and the nurse cells entering the endo-
cycle. However, in stage 4/5 of oogenesis, after under-
going approximately four endocycles, the nurse cells
construct large spindles, condense their DNA, and ar-
rest in a metaphase-like state (Reed and Orr-Weaver,
1997). Entry into this pseudo mitotic-like state is accom-
panied by the unscheduled accumulation of the mitotic
cyclin Cyclin B (Reed and Orr-Weaver, 1997). These
data support the model that restricting the accumulation
of the mitotic cyclins during the prophase I meiotic ar-
rest is fundamental to the maintenance of mitotic quies-
cence.
The translational regulation of gene expression is
a central regulatory mechanism controlling germline de-
velopment and gametogenesis (de Moor et al., 2005; Ta-
dros and Lipshitz, 2005). The arrest (aret) gene encodes
the translational repressor Bruno (Bru), which contains
three RRM-type RNA binding domains (Schupbach
and Wieschaus, 1991; Webster et al., 1997). The Bru pro-
tein was identified biochemically by its ability to bind
Bruno Response Elements (BRE) in the 30 UTR of the os-
kar (osk) mRNA in vitro (Kim-Ha et al., 1995). Subsequent
analysis found that Bru inhibits the precocious transla-
tion of osk prior to its localization to the posterior pole
of the oocyte (Kim-Ha et al., 1995; Markussen et al.,
1995; Rongo et al., 1995). The translational silencing of
osk mRNA is dependent on the presence of BREs in
the osk 30 UTR (Kim Ha et al., 1995; Webster et al.,
1997). Additionally, Bru has also been implicated in the
translational repression of gurken (grk) in early oogene-
sis (Filardo and Ephrussi, 2003). Indeed, the overexpres-
sion of Bru results in anteroposterior and dorsoventral
patterning defects, consistent with a role of Bru in
both osk and grk mRNA regulation (Filardo and Eph-
russi, 2003). However, strong mutations in aret have a tu-
morous phenotype that can’t be explained by the dere-
pression of either osk or grk translation (Parisi et al.,
2001; Webster et al., 1997). This suggests that Bru regu-
lates the translation of additional critical target mRNAs
during oogenesis.
Here, we demonstrate that, upon meiotic entry, Bru in-
hibits the translation of the mitotic cyclin Cyclin A by
binding to BREs in the Cyclin A 30 UTR. In aret mutants,
ovarian cysts enter meiosis but soon accumulate highlevels of mitotic cyclins and return to the mitotic cycle.
Thus, Bru is required to maintain mitotic quiescence
during meiosis. The dual function of Bru in regulating
the translation of genes that influence both the meiotic
program and oocyte differentiation suggests a model
for how cell cycle regulation and gamete differentiation
are coordinated during Drosophila oogenesis.
Results
z2286 Ovarian Cysts Accumulate Mitotic Cyclins
during Meiosis
In order to identify genes that regulate entry into meiosis
and the maintenance of the meiotic program, we
screened a female sterile collection (Koundakjian et al.,
2004) for mutants that produced either too few or too
many cells per ovarian cyst. From this screen, we iden-
tified the mutant z2286. Egg chambers from z2286 fe-
males contain far greater than 16 germline cells
(Figure 1D). Moreover, the germline cells in z2286 egg
chambers do not appear to become polyploid, consis-
tent with the cells remaining in the mitotic cycle and con-
tinuing to divide. The z2286 tumorous ovary phenotype
is 100% penetrant.
To further explore how the cell cycle program of z2286
ovarian cysts is altered, we labeled wild-type and z2286
ovaries with antibodies against Cyclin B and the SC
component C(3)G. In wild-type ovaries, the levels of
the mitotic cyclins Cyclin A and Cyclin B oscillate during
the germline cyst divisions in region 1 of the germarium,
but disappear soon after cysts enter region 2 (Lilly et al.,
2000). In contrast, the SC component C(3)G, which can
be used to follow meiotic progression, is first observed
in region 2 (Page and Hawley, 2001). Thus, in wild-type
ovaries, the levels of the mitotic cyclins are downregu-
lated soon after ovarian cysts enter the meiotic cycle
and form SCs (Figure 1G). In z2286 ovaries, SC formation
occurs with wild-type kinetics, indicating that z2286mu-
tants enter the meiotic cycle (Figure 1H). However, un-
like what is observed in wild-type, in z2286 ovarian
cysts, mitotic cyclin levels accumulate after meiotic en-
try, as indicated by the overlap of Cyclin B and C(3)G
(marked by an asterisk), and remain at high levels in
the germline throughout oogenesis (Figure 1F). Thus,
in z2286 mutants, the meiotic program is turned on, as
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129evidenced by the formation of the SC, but the mitotic
program is not turned off.
During oogenesis, the levels of the mitotic cyclins are
posttranscriptionally regulated (Dalby and Glover,
1992). This can be deduced from the observation that
the Cyclin A and Cyclin B transcripts are present at
high levels in ovarian cysts beginning in region 2 of the
germarium and remain high throughout oogenesis.
However, once ovarian cysts enter the meiotic cycle,
the levels of the Cyclin A and Cyclin B proteins remain
undetectable through stage 13 of oogenesis (Lilly
et al., 2000; Reed and Orr-Weaver, 1997). In situ hybrid-
izations (Figure 2A) and semiquantitative RT-PCR
(Figure 2B) indicate that Cyclin A and Cyclin B are not
transcriptionally upregulated in z2286 mutants. Thus,
the z2286 gene product influences the posttranscrip-
tional inhibition of mitotic cyclin expression.
z2286 Is an Allele of the arrest Gene, which Encodes
the Translational Repressor Bruno
Meiotic mapping placed the z2286 mutation in a region
that contains the known female sterile mutant aret.
Strong alleles of aret have a tumorous phenotype, and
egg chambers contain large numbers of undifferentiated
mitotically active germ cells (Parisi et al., 2001; Schup-
bach and Wieschaus, 1991; Yan and Macdonald,
2004). Complementation analysis indicates that z2286
is an allele of aret (data not shown). Moreover, we find
that the strong aret mutants aretQB and aretWH fail to
downregulate the mitotic cyclins at meiotic entry and
generally have phenotypes indistinguishable from
z2286 homozygotes (data not shown). Placing the
z2286 mutant over Df(2L)esc-P3-0, which uncovers the
aret gene, does not increase the severity of the ovarian
phenotype, indicating that z2286 may be an amorph.
These data demonstrate that z2286 is an allele of the
aret gene, which encodes the known translational inhib-
itor Bru. Additionally, they implicate Bru in the mainte-
nance of mitotic quiescence during meiosis.
Bru and the Mitotic Cyclins Have Reciprocal
Expression Patterns in the Female Germline
To further explore the role of Bru in regulating the accu-
mulation of the mitotic cyclins during oogenesis, we ex-
amined Bru expression relative to the expression of Cy-
clin A. The mitotic cyclins are expressed during the
germline cyst division in region 1, but disappear soon af-
ter entry into meiosis in early region 2 (Figure 1G) (Lilly
Figure 2. Cyclin A and Cyclin B Are Not Transcriptionally Upregu-
lated in z2286 Mutants
(A) In situ hybridization of Cyclin A and Cyclin B in wild-type and
z2286 mutant ovaries.
(B) Analysis of Cyclin A and Cyclin B levels in wild-type and z2286
mutants by semiquantitative RT-PCR.et al., 2000). In contrast, Bru expression is dramatically
upregulated in region 2 at the mitotic/meiotic boundary,
and the levels remain high until late in oogenesis (Web-
ster et al., 1997). Strikingly, double labeling indicates
that Bru and Cyclin A expression are nearly reciprocal,
with the upregulation of Bru coincident with the downreg-
ulation of Cyclin A at the mitotic/meiotic boundary
(Figure 3A). In order to examine the relationship between
Bru and Cyclin A expression in stage-14 egg chambers,
after oocytes have reentered the meiotic cycle, we
probed Western blots with antibodies against Bru and
Cyclin A (Figure 3B). Intriguingly, as oocytes reenter
the meiotic cycle, the levels of Bru decrease coincident
with an increase in the levels of Cyclin A (Fenger et al.,
2000) (Figure 3B). Thus, the temporal distribution of
Bru is consistent with a role for Bru in the inhibition of mi-
totic cyclin expression throughout the prophase I mei-
otic arrest of the oocyte.
Figure 3. Bru versus Mitotic Cyclin Expression in the Female Germ-
line
(A) A wild-type germarium double-labeled with aBru (green) and
aCyclin A (red) antibodies. Note that the downregulation of Cyclin
A at the mitotic/meiotic boundary is temporally coincident with the
upregulation of Bru, resulting in nearly mutually exclusive staining
patterns.
(B) Immunoblotting of Bru (upper) and Cyclin A (lower). Sample (1)
contains germarium to stage-10 egg chambers. Sample (2) contains
stage-14 egg chambers. Note that stage-14 egg chambers have re-
duced levels of Bru and increased levels of Cyclin A relative to those
in earlier stages of oogenesis. A proportion of the Cyclin A present in
sample (1) is contributed by the mitotically active somatic follicle
cells.
(C) Overexpression of Bru reduces Cyclin A protein levels in the
ovary. RNA and protein samples were prepared from wild-type
and mata4-GAL-VP16<USAp-Bru whole ovaries. RNA samples
were examined by semiquantitative RT-PCR. RNA concentrations
were calibrated by using rp49 mRNA as an internal standard. CBB
indicates Coomassie blue staining.
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the germline on the levels of mitotic cyclin expression in
the ovary. Specifically, we drove the transcription of
UASp-Bru (aret.F) by using the mata4-GAL-VP16 driver,
which expresses strongly in the germline beginning in
stage 1 of oogenesis. RNA and protein were simulta-
neously sampled from the same ovarian preparation
for both wild-type and UASp-Bru. While Cyclin A and Cy-
clin B protein levels were reduced in response to Bru
overexpression, Cyclin A and Cyclin B mRNA levels re-
main unchanged (Figure 3C). Consistent with Bru over-
expression preventing the reaccumulation of mitotic cy-
clins at the onset of the meiotic divisions in late
oogenesis, stage-14 oocytes from UASp-Bru<mata4-
GAL-VP16 females have reduced mitotic cyclin levels
relative to wild-type (Figure S1; see the Supplemental
Data available with this article online). These data sup-
port the model that Bru drives the posttranscriptional
downregulation of mitotic cyclin levels in the female
germline.
Bru Binds the Cyclin A 30 UTR
Bruno inhibits the translation of osk during oogenesis by
binding BREs present in the osk 30 UTR (Castagnetti
et al., 2000; Kim-Ha et al., 1995; Lie and Macdonald,
1999; Webster et al., 1997). A pattern search against
predicted gene transcripts in Drosophila with the BRE
consensus (U/A)U(A/G)U(A/G)U(A/G)U(U/A) indicates
that the Cyclin A 30 UTR contains four consensus BRE
sequences (Figure 4A). To determine if the Bru protein
directly binds the Cyclin A 30 UTR, we performed UV
crosslinking experiments (Gunkel et al., 1998; Webster
et al., 1997). Radiolabeled RNA probes from the Cyclin
A 30 UTR were added to ovarian extracts, UV was cross-
linked, and the RNA-protein products were examined
on SDS-PAGE gels by autoradiography. This experi-
ment revealed that the Cyclin A 30 UTR binds a protein
of an apparent molecular weight of 70 kDa (arrow), con-
sistent with the size of the Bru (Figure 4B). Binding of the
70 kDa protein can be competed away with an excess
of the cold-specific competitor oskAB, but it was not
influenced by an excess of nonspecific competitor
(Figure 4B).
To verify that the 70 kDa protein is Bru, we UV cross-
linked ovarian extracts with radiolabled RNAs from the
Cyclin A 30 UTR and then immunoprecipitated the ex-
tracts by using purified aBru antibodies. While an RNA
probe from the 30 UTR of Cyclin A was selectively immu-
noprecipitated with the Bru protein, no signal was ob-
served with a probe from theCyclin A 50 UTR or a shorter
probe from the 30 UTR of Cyclin A that did not contain
a predicted BRE (Figure 4C; data not shown).
In order to confirm that the Bru binds the Cyclin A
mRNA in vivo, we examined if antibodies against Bru
specifically immunoprecipitate the Cyclin A mRNA in
both wild-type and aretQB ovaries. The aretQB mutants
produce a truncated form of Bru that does not contain
the antigen used to generate the aBru serum. Thus, im-
munoprecipitation products from the aretQB ovaries
serve as a negative control. As anticipated, both the
positive control osk mRNA as well as Cyclin A mRNA
are immunoprecipitated by using aBru serum from
wild-type, but not aretQB mutant, ovaries (Figure 4D).
However, it should be noted that, because of the earlyblock in oogenesis, strong aret mutants do not tran-
scribe osk. In contrast, rp49 mRNA is not immunopreci-
pitated with aBru. Moreover, the Cyclin A mRNA is not
immunoprecipitated with antibodies generated against
proteins other than Bru, including aCyclin E (data not
shown). Thus, the Bru protein specifically associates
with the Cyclin A mRNA in vivo.
The Cyclin A 30 UTR Confers Bruno-Dependent
Translational Repression on a Heterologous mRNA
To examine if the 30 UTR of Cyclin A is the primary cis ef-
fector of Cyclin A translational repression, we generated
a reporter construct that contained the 50 and 30 UTRs of
Figure 4. Bru Binds the Cyclin A 30 UTR
(A) Diagram of the Cyclin A transcript and the position of the pre-
dicted BREs. BRE (1), UUGUAUAUU; BRE (2), UUAUAUGUA; BRE
(3), AUGUAUGUU; BRE (4), UUAUAUAUU.
(B) UV crosslinking of ovarian extracts indicates that the Cyclin A 30
UTR specifically binds a protein the size of Bru (68 kDa). The binding
of the Cyclin A 30 UTR probe is competed off with the specific RNA
competitor oskAB, but not with the nonspecific RNA competitor
from BSSK MC.
(C) Immunoprecipitation of UV-crosslinked ovarian proteins by aBru
affinity-purified serum confirms that the approximately 70 kDa pro-
tein that binds the Cyclin A 30 UTR is Bru.
(D) Coimmunoprecipitation of the Cyclin A mRNA with a Bru-con-
taining RNP complex. Ovarian extracts from 0–12 hr posteclosion
ovaries were used for coimmunoprecipitation of mRNAs. Wild-
type (aret+) and aretQB (aret2) coimmunoprecipitated RNA was an-
alyzed by semiquantitative RT-PCR. The lower panel represents an
additional four cycles of PCR relative to the upper panel, demon-
strating that the experiments were performed in the linear amplifi-
cation range. osk is shown as a positive control for Bru binding.
However, in aretQB ovaries, development is arrested prior to the ex-
pression of the osk mRNA. rp49 serves as a negative control.
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131Figure 5. 30 UTR-GFP Reporter Gene Expres-
sion in Wild-Type and aret Ovaries
(A–D) The large panels represent mata4-GAL-
VP16-driven 30 UTR reporter gene expres-
sion. Insets show germaria from ovaries car-
rying the same 30 UTR reporter as the larger
panels, driven by the nosGAL4VP16 driver.
DAPI staining is white, and GFP staining is
green. (A) Wild-type ovaries with no reporter.
The green staining in the dorsal appendages
represents background. (B) The SV40 30
UTR reporter expresses GFP throughout oo-
genesis, indicating that the SV40 30 UTR does
not confer translational regulation during oo-
genesis. (C) The cycA 30 UTR reporter ex-
presses in region 1 and region 2a of germaria
(see inset). However, beginning in mid-region
2, the expression of the cycA 30 UTR reporter
is silenced until approximately stage 13/14.
(D) The expression of the positive control
osk 30 UTR reporter is similar to that observed
with the cycA 30 UTR reporter.
(E) In a nosGAL4VP16< cycA 30 UTR germa-
rium, the GFP (green) expression from the
cycA 30 UTR reporter is downregulated coin-
cident with the upregulation of Bru (Red).
(F–K) Translational derepression of the cycA
30 UTR reporter in aret mutant ovaries. Each
reporter construct was expressed by using the mata4-GAL-VP16 driver in both a wild-type and aret mutant background. The SV40 30 UTR re-
porter expressed in (F) wild-type and (G) aretPA/aret2286 ovaries. The cycA 30 UTR reporter expressed in (H) wild-type and (I) aretPA/aret2286 ova-
ries. Note that the expression of the reporter in the aret mutant is equivalent to the SV40 30 UTR, which is not translationally regulated. The osk 30
UTR reporter expressed in (J) wild-type and (K) aretPA/aret2286 ovaries.
Images of these groups ([A]–[D], [F]–[J], and [G]–[K]) were taken with equal exposure times. In (F)–(K), DNA is in red and GFP is in green.the Cyclin A mRNA, but in which the Cyclin A ORF was
replaced by GFP. As positive and negative controls,
we constructed two additional lines that contained the
30 UTRs of osk and SV40, respectively, downstream of
cycA 50 UTR-GFP (see Experimental Procedures). All of
the constructs were under the control of the UASp pro-
moter (Rorth, 1998). We used two drivers to promote
GAL4 expression in the germline during oogenesis.
The nosGAL4VP16 driver expresses in the germline
throughout oogenesis beginning in region 1 of the ger-
marium (Van Doren et al., 1998). The mata4-GAL-VP16
driver expresses strongly in the germline beginning in
stage-1 egg chambers.
Using mata4-GAL-VP16 or nosGAL4VP16 (inset) to
drive expression of the SV40 30 UTR reporter results in
GFP accumulation in a pattern that reflects the expres-
sion of the GAL4 driver constructs (Figure 5B). Thus,
as anticipated, the SV40 30 UTR does not confer transla-
tional inhibition on the reporter construct. In contrast,
using mata4-GAL-VP16 or nosGAL4VP16 (inset) to drive
the expression of the cycA 30 UTR reporter results in a re-
stricted pattern of GFP accumulation during oogenesis.
Specifically, the levels of GFP are dramatically reduced,
relative to the SV40 30 UTR control, beginning in region 2
of the germarium and remain low until approximately
stage 13/14, at which time the levels of GFP rise dramat-
ically (Figure 5C). The osk 30 UTR reporter, which serves
as a positive control for translational repression via Bru,
results in the accumulation of GFP in a very similar re-
stricted pattern (Figure 5D). Temporally, the repression
of GFP accumulation from the cycA 30 UTR and osk 30
UTR transgenes parallels the expression of the Bru pro-
tein. Indeed, immunostaining of a germarium expressing
the cycA 30 UTR reporter with antibodies against Bru re-veals that the upregulation of Bru in region 2 is tempo-
rally coincident with decreased expression of GFP
from the transgene (Figure 5E).
To assess if the translational inhibition conferred by
the 30 UTR of Cyclin A is dependent on the Bru protein,
we examined the expression of the 30 UTR reporter con-
structs in an aretmutant background. When the reporter
constructs containing either the Cyclin A 30 UTR or the
osk 30 UTR are expressed in an aretmutant background,
the translational inhibition is lost and GFP is expressed
at levels similar to those observed with the SV40 30
UTR reporter construct (Figures 5A–5F). Thus, the trans-
lational repression conferred by the Cyclin A 30 UTR is
Bru dependent.
Weak Alleles of aret and cup Phenocopy
morula/APC2 Mutants
Strong alleles of aret produce a tumorous phenotype in
which cyst cells never fully establish either the nurse cell
or oocyte fate (Parisi et al., 2001). In the heteroallelic
combinations aretPA/aretz2286, aretPA/aretWH, and
aretPA/aretQB, which reduce but do not eliminate aret
function, mitotic cyclin levels are downregulated at the
mitotic/meiotic boundary and oogenesis proceeds nor-
mally, with the nurse cells entering the endocycle and
the oocyte arresting in prophase of meiosis I. However,
in stage 4, the cysts begin to accumulate high levels of
mitotic cyclins (Figures 6A and 6B). In approximately
20% of mutant cysts, the large polyploid nurse cells
condense their chromosomes and form large mitotic
spindles (Figure 6C). This phenotype is reminiscent of
that observed in mr/APC2 mutants, which have a re-
duced ability to degrade the mitotic cyclins (Kashevsky
et al., 2002). The strong similarity between aret and
Developmental Cell
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sis that Bru functions to downregulate mitotic cyclin lev-
els in ovarian cysts.
In wild-type stage-4 egg chambers, the nurse cells un-
dergo an unusual endocycle that functions to reorganize
the chromatin within the nurse cell nuclei. This modified
endocycle is thought to retain some mitotic-like fea-
tures, suggesting that, although below the level of de-
tection, the mitotic cyclins may be present (Reed and
Orr-Weaver, 1997). Thus, the timing of the increased mi-
totic cyclin accumulation observed in egg chambers
from hypomorphic aret and mr mutants may reflect the
relaxed control of mitotic cyclin expression that nor-
mally occurs at this stage of oogenesis. To further ex-
plore the relationship between aret and APC/C in the
inhibition of mitotic cyclin accumulation during oogene-
sis, we made double mutant combinations of aret and
Figure 6. Hypomorphic Alleles of aret and cup Accumulate Mitotic
Cyclins in Mid-Oogenesis
(A and B) An aretPA/aretz2286 ovariole stained with (A) the DNA dye
DAPI and (B) immunostained with antibodies against aCyclinA
(green) and aC(3)G (red). Note that mutant cysts downregulate
Cyclin A expression upon meiotic entry, as determined by C(3)G
staining, in a manner indistinguishable from wild-type. However, in
mid-oogenesis, the levels of Cyclin A dramatically increase, and
the nurse cells begin to condense their DNA.
(C) An aretPA/aretz2286 egg chamber stained with DAPI (red) and
a-tubulin (green) in which the polyploid nurse cells have constructed
spindles and are attempting to undergo an aberrant mitosis.
(D) An aretPA/aretz2286 egg chamber stained with aCyclin A and DAPI
demonstrates (postanaphase) that some nurse cells have low levels
of aCyclin A staining, suggesting that the APC/C is at least partially
functional in aret mutants (arrow).
(E and F) aretPA, mr1/aret2286, mr2 double mutants show a high fre-
quency of metaphase arrest beginning in stage-1/2 egg chambers.
(F) is a higher magnification of an egg chamber that has just budded
off from a germarium.
(G) cup21 ovarian cysts accumulate high levels of Cyclin A in mid-
oogenesis.mr. While ovaries from aretPA/aretz2886 and mr1/mr2
females do not accumulate mitotic cyclins until approx-
imately stage 4, in aretPA, mr1/aret2286, mr2 double mu-
tants, the inappropriate accumulation of mitotic cyclins,
as well as the construction of mitotic spindles, is ob-
served as early as stage 1 or 2 of oogenesis (Figures
6E and 6F). Additionally, these phenotypes are nearly
100% penetrant. These data suggest that both APC/C
and Bru act prior to stage 4 of oogenesis to restrict mi-
totic activity in developing ovarian cysts (Figures 6E
and 6F).
It has recently been reported that the translational re-
pression of osk mRNA by Bru is mediated through the
eIF4E binding protein Cup (Nakamura et al., 2004). Cup
is thought to prevent the binding of eIF4G and thus pre-
clude ribosomal binding to the osk mRNA (Nakamura
et al., 2004; Nelson et al., 2004). In order to examine if
Cup also functions in the translational inhibition ofCyclin
A, we examined if mitotic cyclin expression is dere-
pressed during oogenesis in cup mutants. Immuno-
staining cup21 and cup4506 ovaries for Cyclin A and Cyclin
B revealed that the mitotic cyclins are inappropriately
expressed beginning at approximately stage 5 of oogen-
esis (Figure 6E). Subsequently, a fraction of the mutant
nurse cells condense their chromatin and form mitotic
spindles similar to those found in aret hypomorphic mu-
tants (data not shown). These data suggest that Bru in-
hibits the translation of Cyclin A and osk mRNAs by us-
ing a common Cup-dependent mechanism.
Discussion
Here, we demonstrate that the translational inhibitor Bru
maintains mitotic quiescence during the prophase I mei-
otic arrest of the Drosophila oocyte. In aret mutants,
ovarian cysts enter the meiotic cycle and progress to
pachytene, as indicated by the formation of mature
SCs. However, after meiotic entry, the levels of the mi-
totic cyclins increase, and the germ cells reenter the mi-
totic cycle and continue to proliferate. Thus, Bru func-
tions to inhibit the expression of the mitotic cyclins
after meiotic entry. Our data indicate that Bru accom-
plishes this task in part by binding BREs present in the
Cyclin A 30 UTR and inhibiting its translation. InDrosoph-
ila, Cyclin A is the primary positive regulatory subunit of
the mitotic kinase Cdk1 (Knoblich and Lehner, 1993;
Lehner and O’Farrell, 1990). A similar strategy for main-
taining the prophase I arrest, and the required low levels
of Cdk1 activity, is employed in clams and fish, as well as
many amphibians, in which the translation of Cyclin B is
inhibited until meiotic maturation (Yamashita, 1998).
The phenotype of strong aret alleles is consistent with
Bru acting soon after meiotic entry to downregulate mi-
totic cyclin expression in order to prevent reentry into
the mitotic cycle. However, our data suggest that Bru
functions to inhibit the expression of the mitotic cyclins
throughout the long prophase I meiotic arrest of the oo-
cyte, from the onset of the meiotic cycle in the germa-
rium until oocytes undergo meiotic maturation and
progress to the first meiotic metaphase late in oogene-
sis. This possibility was first suggested by the observed
inverse relationship between the levels of Bru and the
levels of the mitotic cyclins in ovarian cysts. Bru expres-
sion is dramatically upregulated upon entry into the
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high until late in oogenesis. Throughout this period of el-
evated Bru expression, the levels of the mitotic cyclins
remain low. In stage-13/14 oocytes, the situation re-
verses: Bru levels decrease dramatically, while the lev-
els of the mitotic cyclins increase as oocytes resume
meiosis and progress to the first meiotic metaphase.
Additionally, reporter constructs that have the open
reading frame of GFP fused to the BRE containing 30
UTRs of either Cyclin A or osk are translationally re-
pressed in a pattern identical to the endogenous mitotic
cyclins. This restricted pattern of translation is depen-
dent on the presence of the Bru protein. As is found
with the mitotic cyclins, the translational inhibition of
the Cyclin A and osk 30 UTR reporter constructs is re-
leased in stage-13/14 oocytes at the approximate time
of meiotic maturation. Thus, we speculate that, in Dro-
sophila, an important step toward meiotic maturation
and progression to the first meiotic metaphase may be
the destruction and/or inactivation of Bru.
Weak alleles of aret result in an ovarian phenotype
strikingly similar to that observed when the destruction
of the mitotic cyclins is diminished by weak mutations
in the APC/C subunit mr/APC2 (Kashevsky et al., 2002;
Reed and Orr-Weaver, 1997). Ovarian cysts from both
mutants accumulate mitotic cyclins in mid-oogenesis.
The strong phenotypic similarity between mr/APC2 mu-
tants and weak alleles of aret supports the conclusion
that the cell cycle defects observed in aret are a direct
result of the increased accumulation of mitotic cyclins
and are not a secondary effect of a change in cell fate.
Additionally, the mr/APC2 mutant phenotypes demon-
strate that ovarian cysts arrested in prophase of meiosis
I require a functional APC/C (Kashevsky et al., 2002).
Thus, it follows that Bru-mediated translational inhibi-
tion of Cyclin A is not 100% efficient. At some rate,
Cyclin A is translated in ovarian cysts during the pro-
phase I arrest, and the resulting Cyclin A protein must
be degraded by the APC/C to avoid the inappropriate
activation of Cdk1 and reentry into the mitotic cycle.
Thus, our data support a model in which Bru and the
APC/C act to together to downregulate mitotic cyclin
levels in prophase of meiosis I.
Bru overexpression frequently results in ovarian cysts
undergoing a fifth mitotic division (Filardo and Ephrussi,
2003; and I.S. and M.A.L., data not shown). At first it may
seem counterintuitive that the overproduction of Bru,
a protein that inhibits the expression of the mitotic in-
ducer Cyclin A, results in an extra division. However,
these results are consistent with previous work that sug-
gests that lengthening the G2 phase of the cell cycle dur-
ing the ovarian cyst divisions results in an extra round of
mitosis and the production of 32 cell cysts. This unex-
pected inverse relationship between the length of G2
and the number of ovarian cyst divisions was first noted
during the characterization of Tribbles (Mata et al.,
2000). Tribbles promotes the degradation of the Cdc25
homolog string (Grosshans and Wieschaus, 2000;
Mata et al., 2000, Seher and Leptin, 2000). Cdc25 posi-
tively regulates Cdk1 activity. As is observed with Bru,
when Tribbles is overexpressed with the nosGAL4VP16
driver, ovarian cysts undergo a fifth mitotic division prior
to entering the meiotic cycle (Mata et al., 2000). More-
over, overexpressing string, which is predicted toshorten the G2 phase of the cell cycle, reduces the num-
ber of ovarian cyst divisions, resulting in the production
of eight cell cysts. Thus, our data are consistent with
a model in which the extra mitotic cyst division observed
in nosGAL4VP16<UASp-Bru ovarian cysts results from
a lengthening of G2 due to reduced levels of the Cyclin
A protein. However, exactly how and why the length of
the G2 phase of the cell cycle might influence the num-
ber of cyst divisions remains to be explored.
TheCyclin B 30 UTR does not contain a BRE. Thus, the
question arises as to why Cyclin B expression is upregu-
lated in an aret mutant background. We can think of at
least two models, which are not mutually exclusive, by
which to explain this observation. First, Bru may bind
Cyclin B independent of a BRE consensus sequence
and directly inhibits its translation. While this remains
a formal possibility, we find that the Cyclin B 30 UTR
binds Bru weakly in a UV crosslinking assay (data not
shown). Second, the pathway that inhibits the posttran-
scriptional inhibition of Cyclin B accumulation may be
downregulated by Cyclin A/Cdk1 kinase activity. In this
model, increased Cyclin A/Cdk1 activity present in aret
mutants, due to the derepression ofCyclin A translation,
would secondarily result in the increased accumulation
of Cyclin B. This model would explain why Cyclin B lev-
els are upregulated in an aret mutant background even
though the Cyclin B mRNA may not be a direct target
of Bru. Additionally, it would explain why Cyclin B levels
decrease when Bru is overexpressed in the female
germline.
Recent studies indicate that Bru functions to inhibit
osk translation through its association with the eIF4E
binding protein Cup (Nakamura et al., 2004). The current
working model proposes that Bru binds to BREs present
in the 30 UTR of osk. Bru then recruits Cup, which asso-
ciates with eIF4 at the 50 end of the transcript, effectively
blocking the formation of the eIF4 initiation complex.
Our data suggest that Cup may also play a role in the
translational repression of Cyclin A during meiosis. Sim-
ilar to what is observed with weak alleles of aret, we find
that hypomorphic mutants of cup misexpress the mi-
totic cyclins beginning in at approximately stage 5 of oo-
genesis. There are currently no null alleles of cup; there-
fore, it is not clear if Cup is an obligate partner of Bru in
the inhibition of mitotic cyclin expression during oogen-
esis. If Cup were an obligate partner, one would predict
that null alleles of cupwould have a tumorous ovary phe-
notype or undergo an earlier developmental arrest.
However, the available alleles of cup arrest at later
stages of oogenesis. In cupD212 mutants, which contain
a deletion of the conserved eIF4E binding domain, egg
chamber development proceeds normally until late in
oogenesis (Nakamura et al., 2004). These data suggest
that Cup acts with Bru to repress mitotic cyclin expres-
sion independent of the conserved eIf4E binding do-
main, perhaps binding eIF4E by using a noncanonical
sequence (Nelson et al., 2004). Alternatively, Bru may di-
rect some aspects of the translational repression of
Cyclin A, and potentially other targets, independent of
Cup. Finally, it is important to note that while the data
are suggestive, we have not formally demonstrated
that Cup directly affects the translation of Cyclin A. In-
deed, determining whether Cup is an obligate partner
of Bru in the translational inhibition of Cyclin A, as well
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translational inhibition during oogenesis, will provide in-
sight into the molecular function of both the Cup and Bru
proteins.
In the future, studies on the regulation of Bru, as well
as the identification of additional Bru targets, will help
further our understanding of how the meiotic cycle is
temporally coordinated with gamete differentiation dur-
ing oogenesis.
Experimental Procedures
Fly Stocks and Reagents
The EMS-induced mutation aretZ2286 was identified from a collection
of female sterile lines provided by the C. Zuker laboratory (Koundak-
jian et al., 2004). cup4506 and cup21 were provided by A. Spradling
(Keyes and Spradling, 1997). The driver P{GAL4::VP16-nos.UTR}
was provided by R. Lehmann (Van Doren et al., 1998). The P{UASp-
aret.F} Bru overexpression line was provided by A. Ephrussi (Filardo
and Ephrussi, 2003). All additional lines were obtained from the
Bloomington Stock Center.
Transgene Construction and Analysis
To generate the reporter constructs, the cycA 50 UTR, from the 50 end
(50-GACAGTGTCATCTCTAACATTTA-30) to the NcoI site at the start
codon of cycA, was ligated to a NcoI site of the start codon of EGFP.
Near the termination codon of the EGFP, the sequence was changed
to (50-TCTAGAACTTgTACAGCTCGTCCATg-30) to generate an XbaI
site. The CycA 50 UTR-GFP was cloned into a KpnI/XbaI site of the
pUASP vector, and the resultant pUASP-cycA 50 UTR-EGFP-
fs(1)K10 30 UTR construct was used for the additional 30 UTR re-
porter constructs detailed below. To generate the CycA 30 UTR,
50-TCTAGATGTTTTGAGCCGCTGTCATG-30 and 50-CCGCATCTC
GACCATTCTTTgC-30 were used for PCR. To generate the osk 30
UTR, 50-ACTAGTTGGGTTCTTAATCAAGATAC-30 and (50-CTCGAG
CTTCGATAGCAGGGAC-30 were used for PCR. DNA fragments
were amplified by PCR and cloned into pCR4 topo (invitrogen).
Sequence-verified fragments were ligated and cloned into pUASP
(Rorth, 1998). Constructs were injected by Duke University Model
Systems genomics.
Bru Antibody Production
A region of the Bru protein consisting of amino acids 449–605 was
cloned into the pET21 vector (Novagen) to produce a His6-tagged
fusion protein. The fusion protein was expressed in Escherichia
coli BL21 cells and purified on a nickel column before being used
as an antigen to produce rabbit polyclonal anti-BruC antibodies.
For immunoprecipitation experiments, the antiserum was affinity pu-
rified with the Bru c449-605 peptide on a PVDF membrane or with
full-length Bruno protein on NHS-activated Sepharose (Amersham).
Immunostaining and Western Blotting
Immunostaining of ovaries was performed as described by Greider
et al. (2000). The rabbit aBru antibody was used at a concentration
of 1/3000. Other antibodies were used at the following concentra-
tions for immunohistochemistry: aCycA (A12), 1/200; aCycB
(F2F4), 1/100 (Knoblich and Lehner, 1993) (Developmental Studies
Hybridoma Bank, Iowa); FITC-conjugated a–a-Tubulin, clone
DM1A (Sigma), 1/1000; and aC(3)G, 1/3000 (Hong et al., 2003). Sec-
ondary antibodies conjugated to Alexa 488 and Alexa 594 (Molecular
Probes) were used at a concentration of 1/800.
For Western blots, ovaries were hand dissected in Grace’s me-
dium (Invitrogen) and lysed in Laemmli sample buffer. For simulta-
neous RNA and protein analysis, total RNA and protein were pre-
pared by Trizol (Invitrogen) and sampled from the same
preparation. Protein pellets were dissolved by Urea sample buffer
(1% SDS, 6 M urea, 25 mM Tris-HCl [pH 6.8], 1 mM EDTA, 0.7 M 2
mercapto-ethanol) and analyzed by Western blot.
UV Crosslinking and Immunoprecipitations
UV crosslinking experiments were performed according to Gunkel
et al. (1998), with minor modifications as indicated below. As an al-
ternative to PMSF, we used Complete protease inhibitor (Roche)at a final concentration of 13. For UV crosslinking experiments,
a Stratalinker (1 mJ) was used. For immunoprecipitation, RNase-
digested samples were incubated with anti-Bru prebound Protein
A beads for 2 hr at 4ºC.
Immunoprecipitation of Bru RNP Complex
Ovaries were homogenized in IP Buffer (20 mM HEPES [pH 6.8], 150
mM NaCl, 250 mM sucrose, 0.1% Triton-X, 2.5 mM MgCl2, 0.2 U/ml
RNase OUT [Invitrogen]), and were supplemented with Complete
Protease Inhibitor Cocktail (Roche). The homogenate was sonicated
and centrifuged at 10,0003 g for 15 min at 4ºC. The supernatant was
precleared by using rProtein A Sepharose beads (Amersham) and
was used for IP, by using affinity-purified anti-aretC antibody and
rProtein A Sepharose (Amersham). Input and precipitated poly(A)
RNA were analyzed with semiquantative RT-PCR (Tenenbaum
et al., 2002).
Semiquantitative RT-PCR
poly(A) RNA was prepared by a Dynabeads mRNA DIRECT kit
(Dynal) according to manufacture’s instructions. Each cDNA was
primed by random hexamer or T25 of Dynabeads and was reverse
transcribed by SuperscriptII(Invitrogen). Each cDNA sample was
normalized with rp49. All samples were compared in liner amplifica-
tion range.
Primers Used for RT-PCR
RACE1; 50-GCGAGCTCCGCGGCCGCGTTTTTTTTTTTT-30
CycAF3; 50-AGCCATATAAAAGATAGTTGCCA-30
CycAR3; 50-AGAGGTTGAAATATAAAATATCGT-30
CycAR1; 50-TCTCGAAGCTAGCTGTTTCTG-30
CycB FN; 50-GGAAGACCCTGACTTACCTAG-30
CycB RN; 50-TCGCGAGCAACTTGTGCTC-30
Rp49F2; 50-TACAGGCCCAAGATCGTGAA-30
Rp49R2; 50-ACGTTGTGCACCAGGAACTT-30
Supplemental Data
Supplemental Data including Figure S1 are available at http://
www.developmentalcell.com/cgi/content/full/10/1/127/DC1/.
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